{
    "clinical_study": {
        "@rank": "75462", 
        "arm_group": [
            {
                "arm_group_label": "The laryngeal mask airway-ClassicTM (LMA)", 
                "arm_group_type": "Active Comparator", 
                "description": "The LMA is a large foreign body that exerts pressure on the pharyngeal mucosa. High LMA intracuff pressures may reduce pharyngeal mucosal perfusion and lead to throat discomfort."
            }, 
            {
                "arm_group_label": "The AES Ultra CPVTM LMA (Ultra)", 
                "arm_group_type": "Active Comparator", 
                "description": "Ultra is a new supraglottic airway with anatomical features and insertion technique virtually identical to the LMA-ClassicTM. The cuff and the shaft are made of silicone with a built-in CPV pilot balloon valve which provides continuous monitoring of the intracuff pressure. The CPV cuff pressure indicator has 3 zones indicated by color: yellow corresponds to pressure < 50 cm H2O; green 60 cm H2O; and red >70 cm H2O"
            }
        ], 
        "brief_summary": {
            "textblock": "The study compares the incidence of pharyngolaryngeal complications in patients managed with\n      either a pressure-limiting strategy using the AES Ultra CPVTM or a standard practice using a\n      LMA, in ambulatory surgery patients."
        }, 
        "brief_title": "The Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "The Study Focuses on the Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator on Postoperative Pharyngolaryngeal Adverse Events", 
        "detailed_description": {
            "textblock": "Recent evidence suggests that reduction of LMA intracuff pressure may decrease the incidence\n      of pharyngolaryngeal symptoms. Yet, pressure manometers are not widely available limiting\n      the application of a strategy of intracuff pressure reduction. The Ultra airway has been\n      designed to provide continuous indication of intracuff pressure and can limit the intracuff\n      pressure to < 60 cm H2O. This study compares the incidence of pharyngolaryngeal\n      complications in patients managed with either a pressure-limiting strategy using the Ultra\n      or a standard practice using a LMA, in ambulatory surgery patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  American Society of Anesthesiologists physical status I-III\n\n          -  18 to 65 years of age\n\n          -  Ambulatory patients scheduled to undergo knee arthroscopy, transurethral resection of\n             bladder tumor, hand, gynecological, general surgical and eye procedures under a short\n             general anesthesia of less than 2 hours\n\n          -  Spontaneously breathing on the LMA\n\n        Exclusion Criteria:\n\n          -  Reduced mouth opening less than 2.5cm\n\n          -  Recent history of upper respiratory tract infection and sore throats\n\n          -  Contraindications of LMA use (Morbid obesity with body mass index greater than\n             40kg/m2, symptomatic hiatus hernia, esophageal reflux disease)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "170", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01800344", 
            "org_study_id": "11-0392-A"
        }, 
        "intervention": [
            {
                "arm_group_label": "The laryngeal mask airway-ClassicTM (LMA)", 
                "intervention_name": "LMA", 
                "intervention_type": "Device", 
                "other_name": "The laryngeal mask airway-Classic"
            }, 
            {
                "arm_group_label": "The AES Ultra CPVTM LMA (Ultra)", 
                "description": "Ultra", 
                "intervention_name": "Ultra", 
                "intervention_type": "Device", 
                "other_name": "AES Ultra CPVTM LMA (Ultra)"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Airway Cuff", 
            "LMA", 
            "Ultra", 
            "Cuff Pressure", 
            "Ventilation", 
            "Anesthesia", 
            "Intubation"
        ], 
        "lastchanged_date": "February 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5T2S8"
                }, 
                "name": "Univeristy Health Network- Toronto Western Hospital"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator on Postoperative Pharyngolaryngeal Adverse Events: A Prospective, Randomized Trial", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: UHN Research Ethics Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The primary outcome, composite pharyngolaryngeal complication, is defined as the presence of either sore throat, dysphonia or dysphagia at 1, 2, and 24 h postoperatively.", 
            "safety_issue": "No", 
            "time_frame": "1, 2, 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01800344"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Intracuff pressure intraoperative 10 post insertion", 
            "measure": "Intracuff pressure", 
            "safety_issue": "No", 
            "time_frame": "intraoperative"
        }, 
        "source": "University Health Network, Toronto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Health Network, Toronto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}